Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Treatment strategy in schizophrenia combined with eating disorder.

Dadić-Hero E, Ružić K, Grahovac T, Valković T, Petranović D.

Psychiatr Danub. 2011 Mar;23(1):95-7.

PMID:
21448107
[PubMed - indexed for MEDLINE]
Free Article
2.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
3.

Antipsychotic treatment--side-effect and/or metabolic syndrome.

Dadić-Hero E, Ružić K, Grahovac T, Palijan TZ, Petranović D, Sepić-Grahovac D.

Psychiatr Danub. 2011 Mar;23(1):98-100.

PMID:
21448108
[PubMed - indexed for MEDLINE]
Free Article
4.

Olanzapine treatment in anorexia nervosa: case report.

Dadić-Hero E, Ruzić K, Pernar M, Kabalin M, Medved P.

Psychiatr Danub. 2009 Mar;21(1):122-5.

PMID:
19270636
[PubMed - indexed for MEDLINE]
Free Article
5.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
[PubMed - indexed for MEDLINE]
6.

[A rare and not very studied disorder: childhood-onset schizophrenia. A case report].

Bailly D, de Chouly de Lenclave MB.

Encephale. 2004 Nov-Dec;30(6):540-7. French.

PMID:
15738856
[PubMed - indexed for MEDLINE]
7.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
[PubMed - indexed for MEDLINE]
8.

Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.

Dossenbach M, Arango-Dávila C, Silva Ibarra H, Landa E, Aguilar J, Caro O, Leadbetter J, Assunção S.

J Clin Psychiatry. 2005 Aug;66(8):1021-30.

PMID:
16086618
[PubMed - indexed for MEDLINE]
9.

[Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia].

Scholl HP, Kasper S, Danos P, Höflich G, Möller HJ.

Nervenarzt. 1994 Jul;65(7):478-81. German.

PMID:
7800092
[PubMed - indexed for MEDLINE]
10.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
11.
12.

Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.

Dossenbach M, Pecenak J, Szulc A, Irimia V, Anders M, Logozar-Perkovic D, Peciukaitiene D, Kotler M, Smulevich AB, West TM, Lowry AJ, Treuer T.

J Clin Psychiatry. 2008 Dec;69(12):1901-15. Epub 2008 Sep 9.

PMID:
19012820
[PubMed - indexed for MEDLINE]
13.

Quality of life in schizophrenia: a multicenter, randomized, naturalistic, controlled trial comparing olanzapine to first-generation antipsychotics.

Silva de Lima M, de Jesus Mari J, Breier A, Maria Costa A, Pondé de Sena E, Hotopf M.

J Clin Psychiatry. 2005 Jul;66(7):831-8.

PMID:
16013897
[PubMed - indexed for MEDLINE]
14.

[Quality of life and social functioning in schizophrenic patients treated with olanzapine: 1 year follow-up naturalistic study].

Mayoral F, Montejo AL, Bousoño M, González-Torres MA, Olivares JM, Ros S, Sanjuán J, Escobar R, Lara N.

Actas Esp Psiquiatr. 2006 Jan-Feb;34(1):7-15. Spanish.

PMID:
16525900
[PubMed - indexed for MEDLINE]
15.

Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.

Kryzhanovskaya L, Schulz SC, McDougle C, Frazier J, Dittmann R, Robertson-Plouch C, Bauer T, Xu W, Wang W, Carlson J, Tohen M.

J Am Acad Child Adolesc Psychiatry. 2009 Jan;48(1):60-70. doi: 10.1097/CHI.0b013e3181900404.

PMID:
19057413
[PubMed - indexed for MEDLINE]
16.

Substance abuse and the management of medication nonadherence in schizophrenia.

Wilk J, Marcus SC, West J, Countis L, Hall R, Regier DA, Olfson M.

J Nerv Ment Dis. 2006 Jun;194(6):454-7.

PMID:
16772865
[PubMed - indexed for MEDLINE]
17.

Weight gain due to long term antipsychotic treatment of persistent mental disorders.

Tadger S, Melamed Y.

Psychiatr Danub. 2008 Mar;20(1):37-41.

PMID:
18376329
[PubMed - indexed for MEDLINE]
18.

Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.

Smith RC, Lindenmayer JP, Hu Q, Kelly E, Viviano TF, Cornwell J, Vaidhyanathaswamy S, Marcovina S, Davis JM.

Schizophr Res. 2010 Jul;120(1-3):204-9. doi: 10.1016/j.schres.2010.04.001. Epub 2010 May 10.

PMID:
20457512
[PubMed - indexed for MEDLINE]
19.

[A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].

István S, Agoston T, Tamás T, Zoltán J.

Neuropsychopharmacol Hung. 2007 Oct;9(3):115-24. Hungarian.

PMID:
18399029
[PubMed - indexed for MEDLINE]
Free Article
20.

Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.

Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB.

Arch Gen Psychiatry. 2006 Jun;63(6):622-9.

PMID:
16754835
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk